Literature DB >> 14568798

Angiogenesis and the expression of vascular endothelial growth factors A and C in squamous cell carcinoma of the piriform fossa.

Jarrod J Homer1, Michael G Prentice, Lynn Cawkwell, Martin Birchall, John Greenman, Nicholas D Stafford.   

Abstract

BACKGROUND: Angiogenesis is essential for tumor growth and invasion. Vascular endothelial growth factor A (VEGF-A) is a prime mediator of tumor angiogenesis; VEGF-C, another member of the closely related VEGF family of proteins, has major effects on lymphatic endothelial cells and may be important in the process of lymphatic metastasis.
OBJECTIVES: To evaluate the expression of these cytokines in hypopharyngeal squamous cell carcinoma and to ascertain the effects of these proteins on lymphatic metastasis and vascular angiogenesis.
DESIGN: Retrospective analysis of microvessel density and the expression of VEGF-A and VEGF-C.
SETTING: An academic referral center. Subjects Thirty-four patients with stage T2 to T4 squamous cell carcinoma of the piriform fossa.
INTERVENTIONS: Expression of VEGF-A and VEGF-C was determined by immunohistochemistry on formalin-fixed, paraffin-embedded biopsy specimens. Angiogenesis was measured as microvessel density by staining endothelial cells for platelet-endothelial cell adhesion molecule 1/CD31.
RESULTS: Of the 34 tumors, 21 had clinicoradiologic evidence of lymphatic metastasis. Expression of VEGF-C was associated with lymphatic metastasis (P<.001), but not with microvessel density. The VEGF-A expression correlated with microvessel density (P<.001), but neither VEGF-A expression nor microvessel density was associated with lymphatic metastasis.
CONCLUSIONS: The expression of VEGF-C is associated with lymphatic metastasis in squamous cell carcinoma of the piriform fossa. This is not secondary to effects on vascular angiogenesis and is hypothesized to be due to effects on lymphatic endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14568798     DOI: 10.1001/archotol.129.10.1110

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  6 in total

1.  Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinoma.

Authors:  Panayiotis A Kyzas; Dimitrios Stefanou; Anna Batistatou; Niki J Agnantis
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-20       Impact factor: 4.553

2.  VEGF expression and angiogenesis in oral squamous cell carcinoma: an immunohistochemical and morphometric study.

Authors:  Claudiu Mărgăritescu; Daniel Pirici; Alin Stîngă; Cristiana Simionescu; Marius Raica; Laurentiu Mogoantă; Alex Stepan; Domenico Ribatti
Journal:  Clin Exp Med       Date:  2010-04-08       Impact factor: 3.984

3.  Peptidoglycan and muramyl dipeptide from Staphylococcus aureus induce the expression of VEGF-A in human limbal fibroblasts with the participation of TLR2-NFκB and NOD2-EGFR.

Authors:  Marco Adán Juárez-Verdayes; Sandra Rodríguez-Martínez; Mario E Cancino-Diaz; Juan C Cancino-Diaz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08-14       Impact factor: 3.117

4.  Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.

Authors:  Peter Stadler; Kurt Putnik; Thore Kreimeyer; Lisa D Sprague; Oliver Koelbl; Christof Schäfer
Journal:  BMC Cancer       Date:  2006-12-07       Impact factor: 4.430

5.  Expression of vascular endothelial growth factor (VEGF)-C in preoperative biopsy specimens and metastatic foci of regional lymph nodes in submucosal gastric carcinoma.

Authors:  Makoto Ishikawa; Joji Kitayama; Shinsuke Kazama; Hirokazu Nagawa
Journal:  World J Surg Oncol       Date:  2005-01-07       Impact factor: 2.754

6.  Transcriptional activity of human epidermal growth factor receptor family and angiogenesis effectors in locoregionally recurrent head and neck squamous cell carcinoma and correlation with patient outcome.

Authors:  George Pentheroudakis; Nikolaos Angouridakis; Ralph Wirtz; Angelos Nikolaou; Konstantine T Kalogeras; Nicholas Pavlidis; George Fountzilas
Journal:  J Oncol       Date:  2009-10-07       Impact factor: 4.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.